VIB VERMOEGEN AG (VIH1.DE) Forecast, Price Target & Analyst Ratings

FRA:VIH1DE000A2YPDD0

Current stock price

7.88 EUR
-0.18 (-2.23%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VIB VERMOEGEN AG (VIH1.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€11.73
+ 48.86% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 29, 2026

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
€11.73
Upside
+ 48.86%
From current price of €7.88 to mean target of €11.73, Based on 7 analyst forecasts
Low
€11.62
Median
€11.73
High
€12.08

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for VIH1.DE. The average price target is 11.73 EUR. This implies a price increase of 48.86% is expected in the next year compared to the current price of 7.88.

Analyst Ratings & History

Current Analyst Ratings

VIH1 Current Analyst RatingVIH1 Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

VIH1 Historical Analyst RatingsVIH1 Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
VIH1.DE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VIH1.DE.
In the previous month the buy percentage consensus was at a similar level.
VIH1.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 29, 2026

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026
Revenue
YoY % growth
VIH1.DE revenue by date.VIH1.DE revenue by date.
106.749M
3.86%
99.877M
-6.44%
104.368M
4.50%
121.89M
16.79%
131.38M
7.79%
EBITDA
YoY % growth
VIH1.DE ebitda by date.VIH1.DE ebitda by date.
111.811M
1.34%
106.456M
-4.79%
213.008M
100.09%
87.924M
-58.72%
96.798M
10.09%
EBIT
YoY % growth
VIH1.DE ebit by date.VIH1.DE ebit by date.
80.357M
-0.66%
77.505M
-3.55%
73.211M
-5.54%
55.692M
-23.93%
63.852M
14.65%
Operating Margin
VIH1.DE operating margin by date.VIH1.DE operating margin by date.
75.28%77.60%70.15%45.69%48.60%
EPS
YoY % growth
VIH1.DE eps by date.VIH1.DE eps by date.
N/A
-43.54%
N/A
9.38%
N/A
-35.58%
1.94
10.47%
2.18
12.63%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VIH1.DE Yearly Revenue VS EstimatesVIH1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
VIH1.DE Yearly EPS VS EstimatesVIH1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

VIB VERMOEGEN AG / VIH1.DE Forecast FAQ

What is the price target for VIH1 stock?

7 analysts have analysed VIH1.DE and the average price target is 11.73 EUR. This implies a price increase of 48.86% is expected in the next year compared to the current price of 7.88.

Can you provide the upcoming earnings date for VIB VERMOEGEN AG?

VIB VERMOEGEN AG (VIH1.DE) will report earnings on 2026-04-29.